5-hydroxydecanoate has been researched along with Peripheral Nerve Diseases in 1 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, LH | 1 |
| Sun, YT | 1 |
| Chen, YF | 1 |
| Lee, MY | 1 |
| Chang, LY | 1 |
| Chang, JY | 1 |
| Shen, MR | 1 |
1 other study available for 5-hydroxydecanoate and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Integrating Image-Based High-Content Screening with Mouse Models Identifies 5-Hydroxydecanoate as a Neuroprotective Drug for Paclitaxel-Induced Neuropathy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Calcium Signaling; Cell Line, Tumor; Cell Survival; Deca | 2015 |